For the 30 percent of clinically depressed people who don’t respond to medication, the U.S. Food and Drug Administration recently approved a new, noninvasive treatment option. With NeuroStar TMS, a wand held over the head delivers highly focused magnetic pulses to a part of the brain that’s been linked to depression. A typical course of treatment would involve 40-minute sessions at a psychiatrist’s office five times a week for four to six weeks. In two clinical trials, roughly half of patients said that their symptoms were reduced by at least 50 percent.
Courtesy of Neuronetics
Product: NeuroStar TMS Therapy system
Cost: Approximately $6,000 for a course of 20 to 30 sessions, depending on the provider
Subscribe to Continue Reading
Uh oh–you've read all of your free articles for this month.
With Neuralink, Elon Musk Promises Human-to-Human Telepathy. Don’t Believe It.
Why the billionaire is wrong that telepathy technology will be available in a few short years.
The World’s Most Expensive Medicine Is Being Pulled from the Market
The maker of the gene therapy Glybera says it doesn’t have enough customers.
When Even Genome Sequencing Doesn’t Give a Diagnosis
The technology has been touted as a powerful diagnostic tool, but it doesn’t provide answers to everyone.